The "CRISPR-based Gene Editing Market by Product & Service, by Application, by End-User, and By Region" report has been added ...

CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...

PRNewswire Bengaluru Karnataka [India] January 16 Bengaluru-based biotechnology startup CrisprBits Private Limited has ...

"We’re in very different place," the CEO of Editas says, citing the CRISPR pioneer's plans to get its first treatments into ...

CRISPR-Cas9 pioneer presented with National Medal of Technology and Innovation in White House awards ceremony.

Synthego, a leading supplier of CRISPR solutions, has entered a strategic licensing agreement with global biopharmaceutical company AstraZeneca. This agreement grants Synthego a global license to ...

The new Express License service removes barriers to accessing this transformative gene editing technology for startups.An ...

Lehigh University bioenginering researcher Tomas Gonzalez-Fernandez recently secured funding through the National Science ...

received the National Medal of Technology and Innovation in recognition of his work developing the revolutionary gene-editing tool CRISPR-Cas9. According to the citation from the US Patent and ...

The three-year partnership is another example of Vertex’s interest in improving on Casgevy, its CRISPR medicine for sickle ...

"CRISPR is a gene-editing tool that makes precise DNA changes ... 2025 /PRNewswire/ -- According to the latest study from BCC Research, the demand for CRISPR Technology: Global Markets was valued at ...

"CRISPR is a gene-editing tool that makes precise DNA changes ... This report on CRISPR technology offers market predictions through 2029, examining how CRISPR is used across different fields ...